N-[1-(5-Methyl-1,3,4-thiadiazol-2-yl)azetidin-3-yl]cyclohex-3-ene-1-carboxamide

Modify Date: 2025-08-26 16:55:30

N-[1-(5-Methyl-1,3,4-thiadiazol-2-yl)azetidin-3-yl]cyclohex-3-ene-1-carboxamide structure
 Common Name N-[1-(5-Methyl-1,3,4-thiadiazol-2-yl)azetidin-3-yl]cyclohex-3-ene-1-carboxamide
CAS Number 2415524-22-8 Molecular Weight 278.38
Density N/A Boiling Point N/A
Molecular Formula C13H18N4OS Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name N-[1-(5-Methyl-1,3,4-thiadiazol-2-yl)azetidin-3-yl]cyclohex-3-ene-1-carboxamide

 Chemical & Physical Properties

Molecular Formula C13H18N4OS
Molecular Weight 278.38

 Preparation

Cc1nnc(N2CC(NC(=O)C3CC=CCC3)C2)s1
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
2-[4-(4-fluorophenyl)piperazin-1-yl]-N-phenylpteridin-4-amine
946290-92-2
2-(4-benzylpiperazin-1-yl)-N-phenylpteridin-4-amine
946350-18-1
N-phenyl-2-(4-phenylpiperazin-1-yl)pteridin-4-amine
946218-72-0
N~2~-cyclopentyl-N~4~-phenylpteridine-2,4-diamine
946298-75-5
N2-phenethyl-N4-phenylpteridine-2,4-diamine
946218-86-6
N2-(2-morpholinoethyl)-N4-phenylpteridine-2,4-diamine
946298-78-8
N2-(4-fluorophenyl)-N4-phenylpteridine-2,4-diamine
946350-38-5
N2-(3-fluorophenyl)-N4-phenylpteridine-2,4-diamine
946218-90-2
N2-(3-chloro-4-methoxyphenyl)-N4-phenylpteridine-2,4-diamine
946291-16-3
3-methoxy-1-methyl-N-(3-(trifluoromethyl)phenyl)-1H-pyrazole-4-carboxamide
1013757-67-9
Chemsrc provides CAS#:2415524-22-8 MSDS, density, melting point, boiling point, structure, etc. Its name is N-[1-(5-Methyl-1,3,4-thiadiazol-2-yl)azetidin-3-yl]cyclohex-3-ene-1-carboxamide>> amp version: N-[1-(5-Methyl-1,3,4-thiadiazol-2-yl)azetidin-3-yl]cyclohex-3-ene-1-carboxamide

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved